Longmeng Li Selected Research

Longmeng Li Research Topics

6	Neoplasms (Cancer) 11/2023 - 10/2020
3	Tuberculosis (Tuberculoses) 05/2021 - 08/2017
2	Infections 01/2018 - 08/2017
1	Glioma (Gliomas) 06/2022
1	Extensively Drug-Resistant Tuberculosis 05/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2018

2	Liposomes (Liposome)IBA 06/2022 - 01/2018
2	IntegrinsIBA 01/2022 - 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	InterferonsIBA 01/2023
1	LipidsIBA 06/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	GadoliniumIBA 10/2020
1	Contrast MediaIBA 10/2020
1	IronIBA 10/2020
1	AerosolsIBA 01/2018
1	VaccinesIBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2018
1	Subunit VaccinesIBA 08/2017
1	AntigensIBA 08/2017

3	Therapeutics 11/2023 - 01/2022
2	Immunotherapy 11/2023 - 01/2023
2	Phototherapy (Light Therapy) 11/2023 - 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Combined Modality Therapy 01/2023
1	Photochemotherapy (Photodynamic Therapy) 06/2022
1	Lasers (Laser) 01/2021
1	Intravenous Injections 01/2021